Venturi Wealth Management LLC raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 3,347.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 586 shares of the company’s stock after purchasing an additional 569 shares during the quarter. Venturi Wealth Management LLC’s holdings in Henry Schein were worth $41,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in the company. Truist Financial Corp purchased a new position in shares of Henry Schein during the 4th quarter valued at $257,000. CIBC Asset Management Inc grew its holdings in shares of Henry Schein by 1.0% during the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock valued at $1,235,000 after acquiring an additional 169 shares in the last quarter. Sanctuary Advisors LLC grew its holdings in shares of Henry Schein by 5.0% during the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company’s stock valued at $294,000 after acquiring an additional 203 shares in the last quarter. Allworth Financial LP grew its holdings in shares of Henry Schein by 180.7% during the 4th quarter. Allworth Financial LP now owns 946 shares of the company’s stock valued at $71,000 after acquiring an additional 609 shares in the last quarter. Finally, Figure 8 Investment Strategies LLC purchased a new position in shares of Henry Schein during the 4th quarter valued at $538,000. 96.62% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on HSIC shares. Wells Fargo & Company started coverage on shares of Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target on the stock. Jefferies Financial Group upped their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Barrington Research upped their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a report on Thursday, January 30th. Finally, StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Eight investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $80.09.
Henry Schein Stock Down 2.3 %
Shares of HSIC opened at $75.82 on Wednesday. The company has a 50-day simple moving average of $74.25 and a 200-day simple moving average of $72.43. The firm has a market capitalization of $9.45 billion, a P/E ratio of 31.20, a P/E/G ratio of 2.13 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63.
Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.66 EPS. On average, equities research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Investing in Travel Stocks Benefits
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Do ETFs Pay Dividends? What You Need to Know
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.